Harrow, Inc.
HROW
#6082
Rank
โ‚น106.46 B
Marketcap
โ‚น2,840
Share price
-3.80%
Change (1 day)
-21.11%
Change (1 year)

Revenue for Harrow, Inc. (HROW)

Revenue in 2026 (TTM): โ‚น25.20 Billion

According to Harrow, Inc.'s latest financial reports the company's current revenue (TTM ) is โ‚น26.65 Billion. In 2025 the company made a revenue of โ‚น24.44 Billion an increase over the revenue in the year 2024 that were of โ‚น17.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Harrow, Inc. from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น25.20 B3.1%
2025 โ‚น24.44 B42.75%
2024 โ‚น17.12 B58%
2023 โ‚น10.83 B47.84%
2022 โ‚น7.33 B35.9%
2021 โ‚น5.39 B50.93%
2020 โ‚น3.57 B-2.04%
2019 โ‚น3.64 B26.13%
2018 โ‚น2.89 B69.22%
2017 โ‚น1.70 B26.15%
2016 โ‚น1.35 B109.88%
2015 โ‚น0.64 B513.68%
2014 โ‚น0.10 B16930.45%
2013 โ‚น0.61 M-88.72%
2012 โ‚น5.47 M
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น56.86 B 113.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.86 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA